How You Can Use Solazyme to Understand Industrial Biotech at Renewable Energy Group

Solazyme tailors renewable oils to meet the unique specifications of its customers. Renewable Energy Group harbors a similar, but overlooked, ability with its industrial biotech platform.

May 16, 2014 at 12:12PM

Earlier this week I described three things I learned from a visit to Solazyme (NASDAQ:SZYM) the day after the company's first-quarter conference call. The fourth thing I learned was how close it was to the headquarters of the REG Life Sciences division of Renewable Energy Group (NASDAQ:REGI) (it's 0.3 miles away, or just an eight-minute walk). The two companies are different in many ways, including access to capital, developmental progress, and the number of commercial-scale facilities. Development is one thing; opportunity is another -- and I believe investors should look deeper into the opportunity presented by Renewable Energy Group's entrance into industrial biotechnology. In fact, Solazyme provides an excellent example to describe the robust product portfolio under development at REG Life Sciences. It all comes down to tailored products.

Tailored oils from Solazyme
A little over one year ago, Solazyme announced that it had developed the ability to control the positioning of functional groups at the end of the fatty acid chains that make up its triglyceride oils. Whoa, whoa, whoa! What's that? Triglyceride oils consist of three fatty acid chains attached to a glycerol backbone and are traditionally sourced from plant oils and animal fats. Algal oils should improve on purity, concentration, and sustainability metrics compared with current sources -- major improvements indeed.

G

Source: Solazyme.

So what does Solazyme mean when it talks about tailored oils? Engineers at the company have the ability to specify chain length, or the amount of carbon atoms in each fatty acid.

G

Each intersection of two black lines represents a single carbon atom with two hydrogen atoms bonded to it. Source: Solazyme.

Engineers have the ability to control saturation along each fatty acid chain, or the number of hydrogen atoms bonded to each carbon. A double bond between two carbon atoms replaces two hydrogen atoms -- yielding different characteristics for the finished oil product.

G

Source: Solazyme.

And finally, Solazyme can control the positioning of functional groups that cap the end of each fatty acid chain, which again yields specific characteristics.

G

Source: Solazyme.

Algae naturally produce oil, so understanding how specific genes and environmental conditions affect production gives Solazyme an advantage in strain development compared with industrial biotech companies engineering novel metabolic pathways into their host organisms. Renewable Energy Group has a similar advantage when it comes to tailoring fatty acid production in E. coli.

Tailored fatty acids from Renewable Energy Group
The platform of REG Life Sciences (formerly LS9) is built on the backs of E. coli cells -- the organism that gave rise to biotechnology decades ago by producing human insulin -- and their ability to produce fatty acids. In fact, it's the primary metabolism for the bacterium and sports a 90% energetic efficiency. The platform can use C5 and C6 (five and six carbon) sugars and glycerol, the most abundant byproduct of biodiesel production, as feedstock, while engineers can leverage the deep understanding of E. coli to quickly and simply engineer new strains. Similar to Solazyme, Renewable Energy Group has developed numerous ways to tailor fatty acid molecules for cost-advantaged products.

G

Source: Renewable Energy Group.

The ability to tailor saturation, branching, chain length, hydroxyl groups, and functionality will allow Renewable Energy Group to cash in on a diverse range of products including surfactants (similar to Lux bar soap made with Solazyme algal oils), flavors, fragrances, plastics (similar to Solazyme's waste product stream), lubricants, fuels, and more. Molecules can be made with as few as eight and as many as 33 carbon atoms -- offering various value opportunities. Additionally, tailoring products within the same metabolic range requires less and less work each time. Consider the time required to develop the first three fatty alcohols (products 2-4 represented by the red, purple, and green boxes).

G

Source: Renewable Energy Group.

There's an enormous opportunity for product development, too. Each product family has over 100 possible structures. Not every structure will have commercial potential, but it's good to have options.

G

Source: Renewable Energy Group.

Speaking of options, engineers have demonstrated over 1,000 unique products with the fatty acid platform.

G

Source: Renewable Energy Group.

Of course, Renewable Energy Group has yet to announce commercial plans for REG Life Sciences and its disruptive industrial biotech platform, although management plans to announce formal development plans and partnerships in the next 12-18 months. The company believes it can leverage its extensive transportation, logistics, and feedstock sourcing networks to aid in developing its new assets. It may be challenging to utilize a full commercial scale facility with just a handful of products, but management is quick to note the advantages of co-locating a new facility with one of its existing biodiesel facilities in the Corn Belt. The company may also seek to lease production capacity to other companies as a toll manufacturer to offset costs and minimize downtime. We'll have to wait for more details before we speculate too much.

Foolish bottom line
Is Solazyme well ahead of Renewable Energy Group in terms of commercialization and development of its industrial biotech platform? Yes, but that doesn't make the opportunity for REG Life Sciences any less significant. The company's ability to tailor fatty acids, similar to the way Solazyme tailors the fatty acid chains that comprise its triglyceride oils, has great potential to create long-term value for investors. There's a long road ahead, but Renewable Energy Group is well positioned to turn industrial biotech into an avenue for growth.

OPEC is absolutely terrified of this game-changer
Solazyme and Renewable Energy Group are working hard to make OPEC irrelevant, but they have a few decades to go to achieve their goal. Now, imagine a company that rents a very specific and valuable piece of machinery for $41,000 per hour. (That's almost as much as the average American makes in a year!) And Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report reveals the company we're calling OPEC's Worst Nightmare. Just click here to uncover the name of this industry-leading stock, and join Buffett in his quest for a veritable landslide of profits!

Maxx Chatsko owns shares of Renewable Energy Group. Check out his personal portfolioCAPS page, or previous writing for The Motley Fool, or his work for SynBioBeta to keep up with developments in the synthetic biology industry.

The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers